BIOF BLUE BIOFUELS, INC.

Overview and Growth

Fiscal 2025 results for BLUE BIOFUELS, INC. included net loss of $2.87M. Diluted earnings per share were -$0.01, translating the period’s attributable earnings into the amount reported for each diluted share. A diluted share base of 312.19M links the aggregate earnings figure to diluted EPS and helps frame the per-share comparison. The diluted share count was 2.7% higher than fiscal 2024, when diluted shares averaged 303.85M, adding context to the EPS comparison. At period end, total assets were $1.41M, framing the scale of the company’s operating and financing commitments.

Profitability

The company recorded an operating loss of $3.72M after the reported operating expense base. The company ended the period with a net loss of $2.87M, extending the operating result through all remaining items. The company reported negative EBITDA of $3.57M, adding a pre-interest, tax, depreciation, and amortization view of the operating shortfall. Relative to total assets, the net loss represented 204.3%. The bottom-line deficit increased from $1.42M in fiscal 2024 to $2.87M.

Liquidity and Capital Structure

At period end, the $1.41M asset base was financed through $5.11M of liabilities and -$3.71M of equity. Equity was negative at -$3.71M, meaning liabilities exceeded the residual book value available to shareholders and weakening balance-sheet resilience. The near-term balance sheet paired $76.75K of current assets with $2.98M of current liabilities at the reporting date. The current ratio was 0.03x; current liabilities exceeded current assets, leaving a short-term liquidity deficit. Reported cash and equivalents were $65.20K, separating immediately recognizable cash resources from the rest of the current-asset base. The cash balance equaled 2.2% of current liabilities, showing how much near-term coverage came from cash alone. Equity equaled -263.3% of assets, showing the shareholder-capital layer within the company’s balance sheet. The liabilities-to-assets relationship was 363.3%, placing reported obligations against the full positive asset balance. Cash and equivalents equaled 4.6% of total assets, showing the liquid cash component within the company’s broader resource base. Compared with $1.39M in fiscal 2024, the current asset base moved 1.3% and finished higher. The reported cash balance changed 33.6% from $48.80K in fiscal 2024, ending higher year over year.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $845.00K, rather than cash generation from operations. The company spent $68.90K on capital expenditures while operations also absorbed cash, so both ongoing activity and investment drew on liquidity during the period. The company recorded a $913.90K cash deficit after capital spending for the period. The free-cash-flow deficit equaled 64.9% of total assets, placing the cash shortfall against the company’s resource base. Cash absorbed by operations decreased from $1.00M in fiscal 2024 to $845.00K.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Oct 21, 2026.